NCT06835569 2026-03-09
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Alterome Therapeutics, Inc.
Phase 1 Recruiting
Alterome Therapeutics, Inc.
Pfizer
Pfizer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Al-Azhar University